Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular Purine Nucleotides and Phosphorylated Molecular Patterns are a heterogeneous group of signaling molecules that act as potent triggers for the innate immune system (Di Virgilio et al., 2020). Adenosine triphosphate (ATP) and adenosine diphosphate (ADP), while primarily intracellular, are released into the extracellular space during cell stress or necrosis, where they function as Damage-Associated Molecular Patterns (DAMPs) by activating purinergic P2 receptors (Trautmann, 2009). Similarly, phosphorylated Pathogen-Associated Molecular Patterns (PAMPs), such as the lipid A component of bacterial lipopolysaccharide (LPS), initiate inflammatory cascades through Toll-like receptors (Peters et al., 2014). In pathological conditions like sepsis and acute kidney injury, the systemic accumulation of these phosphorylated molecules drives hyper-inflammation and organ failure. Therapeutic interventions, such as the administration of alkaline phosphatase (e.g., ilofolstat), target these molecules by enzymatically removing their phosphate groups (Pickkers et al., 2018). This dephosphorylation detoxifies endotoxins and converts pro-inflammatory ATP into adenosine, which exerts anti-inflammatory and tissue-protective effects.
Enzymatic dephosphorylation and detoxification of pro-inflammatory ligands into non-toxic or anti-inflammatory metabolites.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular Purine Nucleotides and Phosphorylated Molecular Patterns (eATP/PAMPs).